Purpose: To investigate the retinal biocompatibility of Brilliant Blue G with deuterated water (BBG-D2O) as a vital dye for chromovitrectomy. Methods: In this animal study, 0.05 mL of 0.25 g/L Brilliant Blue G (BBG) associated with 0.13 mL/mL of deuterium oxide (D2O) was injected intravitreally in the right eye and the same amount of balanced salt solution (BSS) was injected similarly in the left eye of rabbits. Clinical examination and histology with light microscopy were performed after seven days. Retinal cell layers were evaluated for morphologic alterations. Electroretinographic (ERG) changes were also assessed at baseline and 7 days after the injections. Results: A total of 6 rabbits were included in the study. The gross histopathologic appearance of the retina, choroid, sclera and optic nerve was within normal limits without any sign of severe retinal necrosis or cystic degeneration. Light microscopy showed that BBG-D2O caused no substantial alterations in retinal layers as compared to control eyes. The injection of BBG-D2O did not induce considerable functional ERG alterations. Conclusion: Intravitreal injection of BBG-D2O 0.25 g/L seems to induce no retinal toxicity as documented by lack of functional and histological changes.
INTRODUCTION
Chromovitrectomy refers to staining of preretinal membranes and tissues to facilitate their intraoperative visualization and removal. 1 Indocyanine green (ICG) was initially shown to avidly stain the internal limiting membrane (ILM). 2 However, numerous articles have raised concerns over retinal toxicity after intravitreal injection of ICG. [3] [4] [5] Later, newer vital dyes emerged as alternatives, such as trypan blue (TB), triamcinolone acetonide (TA) and brilliant blue G (BBG). [6] [7] [8] However, the blue dyes may stain epiretinal membranes (ERMs) rather than ILM elements, while TA deposits substantially in the acellular vitreous. [9] [10] [11] [12] [13] Furthermore, the exact risk of BBG and TB retinal toxicity is not well defined but under investigation. [14] [15] [16] [17] [18] [19] [20] [21] [22] Thus, the best vital dye in terms of retinal compatability and high affinity for the acellular ILM and ERM is yet to be determined. BBG is approved for intraocular use and commercially available at a concentration of 0.25%. The dye should be injected into the fluid-filled globe and washed out immediately to prevent ocular damage. However, efforts are made to achieve higher dye concentrations directly on the surface of the ILM and prevent uncontrolled distribution of the dye within the vitreous cavity by adding heavy water (D2O, deuterium oxide) to the solution.
In the current study, BBG-D2O was tested in a rabbit model for retinal toxicity. The goal was to investigate the in vivo retinal biocompatibility of this dye injected intravitreally into rabbits eyes by clinical examination, histology using light microscopy (LM) and electroretinography (ERG).
METHODS

Dye Solutions, pH, Osmolarity, and Light Absorption Properties
Portions of 5 mg of BBG, in powder form, were weighed with an analytical balance (MettlerToledo Inc., Columbus, USA) and dissolved in 10 mL of the solvent, balanced salt solution (BSS), to obtain a concentration of 0.25 g/L. The mixtures were shaken for 5 minutes and sonicated (Unique Ind., Idaiatuba, Brazil) to obtain a complete solution. The pH was measured with a pH meter (Quimis Inc., Diadema, Brazil), while osmolarity was determined with an osmometer (Advanced Instruments Inc., Norwood, USA). Heavy brilliant blue G was created by adding D2O (water containing a higher-than-normal proportion of the hydrogen isotope deuterium) at a concentration of 0.13 mL/mL. Spectral absorption was measured with a spectrometer between 200 and 1,000 nm immediately after preparation (Spectronic Genesys 5 spectrophotometer, Milton Roy, Warminster, PA, USA).
Dye preparations that were well mixed and sonicated produced complete solutions for injection. The dye was prepared in a solution with BSS to achieve a concentration of 0.25 g/L associated with 0.13 mL/mL of D2O. The osmolarity of selected dyes for experiments ranged from 267 mOsm to 315 mOsm, while pH values were within 6.84 and 7.33.
Animals and Surgical Technique for Intravitreal Injection
A total of 6 male Dutch-belted rabbits, weighing 1.8 to 2.5 kg, were used in accordance with the ARVO statement, "Principles of Laboratory Animal Care" (NIH publication No. 85-23, revised 1985), the OPRR Public Health Service Policy on the Humane Care and Use of Laboratory Animals (revised 1986) and the US Animal Welfare Act, as well as university and national guidelines for research on animals.
After placing a lid speculum, a drop of 5% povidone-iodine was instilled followed by BSS washout. The vitreous cavity was accessed through the superotemporal sclera 2 mm posterior to the limbus using a 27-gauge needle connected to a 1 mL syringe containing dye or BSS. The animals were given an injection of 0.05 mL of 0.25 g/L BBG associated with 0.13 mL/mL of D2O into the right eye vitreous cavity, while the left eyes were injected with 0.05 mL of BSS (290 mOsm) serving as the control group. Eyes were immediately examined by indirect ophthalmoscopy; one drop of antibioticsteroid solution (0.5% moxifloxacin and 0.1% dexamethasone) was then instilled in each eye.
Clinical Evaluation
Biomicroscopy and indirect ophthalmoscopy (Keeler Instruments, Broomall, USA) was performed immediately after the injection and at seven days to evaluate corneal transparency, conjunctival reaction, appearance of the lens and retina, and vitreous haze.
In vivo Retinal Functional Toxicity
ERG recordings were taken at baseline and 7 days after the intravitreal injections. The rabbits were kept in a dark room for 30 minutes and anesthetized with an intramuscular injection of a solution containing 1 mL of ketamine (50 mg/ mL) and 0.4 mL of xylazine (10 mg/mL). The pupils were dilated with 1% tropicamide eye drops and the cornea was anesthetized with 1% proparacaine drops. The rabbits were placed on a heating pad during the experiment and unipolar contact lenses with ERG jet electrodes (Universe SA, La Chaux-de-Fons, Switzerland) were placed on both corneas with 2% methylcellulose (Ophthalmos, São Paulo, Brazil).
A reference electrode filled with electrolytic gel was placed at the temporal canthus, while the ground electrode was also filled with gel and placed on the earlobe. They were then presented in a Veris System Ganzfeld stimulator (ElectroDiagnostic Imaging Inc., San Mateo, USA). After 30 minutes of dark adaptation, the procedure was performed according to two types of responses: scotopic rod response and scotopic maximal response. The responses one week after injection were compared to baseline levels and a decrease in post-injection values exceeding 50% was considered as remarkable.
Data were presented as median (range) values. Pre-and postinjection comparisons were performed using the Wilcoxon signed rank test. P-values less than 0.05 were considered as statistically significant. All analyses were performed employing Stata software version 11 (College Station, Texas, USA).
In-vivo Morphologic Retinal Toxicity and Light Microscopy
The rabbits were euthanized with an intravenous injection of 120 mg/kg sodium pentobarbital one week after the intravitreal injections and their eyes were enucleated. The eyes were sectioned in half and fixed at 4˚C in a mixture of 2.5% glutaraldehyde and 4% paraformaldehyde in 0.1 M phosphate buffer at pH 7.4. The specimens were stained en bloc with lead citrate, washed three times in 0.1 M phosphate buffer and dehydrated with ethyl alcohol. The specimens were embedded and stained with 1% toluidine blue and examined with an Optiphot-2TM (Nikon, Tokyo, Japan) for LM. Samples were obtained from two different areas in all dyeinjected eyes in three serial sections: 500 µm inferior to the optic nerve and 4 mm from the optic nerve in the temporal-inferior quadrant. An area 1100 µm in diameter of the retinal surface was used for detailed analysis of retinal toxicity. For histologic evaluation of the degree of cellular injury, retinal layers were analyzed individually for cellular abnormalities such as vacuolization, edema and necrosis. The results were described as absence of changes, focal abnormalities with less than 12 damaged cells, or diffuse changes with more than 12 damaged cells. Eyes were examined by two masked examiners to avoid bias. The inner (INL) and outer (ONL) nuclear layers were counted for the number of cells with the ImageJ software (National Institues of Health, Bethesda, MD, USA) within the 1,100 micrometer retinal surface. The eyes of the dye group were compared with the BSS-control group; statistical analysis was performed using analysis of variances (ANOVA) followed by the Newman-Keuls test with a specific software program (GraphPad Software Inc., San Diego, CA, USA).
RESULTS
Clinical Evaluation
Promptly after intravitreal injection, the dye appeared in the vitreous cavity as a blue floating mass. At clinical examination immediately and 7 days after dye injection, all eyes were negative for cataracts, hemorrhage, retinal detachment and intraocular opacities.
Morphologic Retinal Toxicity with Light Microscopy
The histology of both BBG-injected and control eyes showed no major anatomical signs of toxicity. The histopathologic appearance of the retina, choroid and sclera was within normal limits without any sign of severe retinal necrosis or cystic degeneration.
The nerve fibre layer, retinal pigment epithelium (RPE) and choriocapillaris appeared normal after 7 days in both groups; both groups showed vacuolization and edema only in sparse regions of the retina (Figure 1 
Evaluation of Retinal Function with Electroretinography
No considerable alterations in ERG were found during the follow-up period. 
DISCUSSION
The use of vital dyes in vitrectomy facilitates intraoperative surgical maneuvers such as ILM or ERM peeling.
1-3 Some dyes available for chromovitrectomy such as ICG and TB may cause complications in macular surgery such as migration into the subretinal space and alterations in the RPE, and perimetric and papillary defects. 4, 23, 24 In this rabbit model, the retinal biocompatibility of BBG with deuterated water was determined to evaluate the use of this dye as an alternative in chromovitrectomy. Our study showed that BBG-D2O at a dose of 0.25g/L caused no severe functional or morphologic retinal toxicity in this animal model. Another study using cell culture found that BBG-D2O is safe based on ERG values. 25 Therefore, BBG-D2O may be useful and should be considered for application in chromovitrectomy. We used ERG B-wave amplitude as a criterion for evaluating retinal function in rabbits as it is the most relevant parameter for drug toxicity.
Compared to cell culture alone, animal models are usually considered to provide better evidence of pharmacological activity since it better simulates the human ocular and retinal environment. However, our results may not exactly correspond to the results in human chromovitrectomy due to interspecies variations. In our study, we did observe considerable anatomical or functional damage to the retinal layers. Considering the longer duration of dye exposure by the retina in the current study as compared to the shorter time of application during vitrectomy, we may assume that toxicity is even less likely during surgical procedures in humans. However one should consider the possibility of enhanced toxicity due to light exposure.
Drawbacks to our study include: (1) testing only one concentration of the dye in contrast to the large number of concentrations that can be examined in cell culture studies. (2) We did In summary, intravitreal injection of BBG-D2O did not induce significant anatomical or functional toxicity in the retina in this animal model. However this agent should be studied further to prove its capacity to stain preretinal membranes and the vitreous with tolerable toxicity. Future surgical experience will help improve the use and interpretation of new dyes in chromovitrectomy.
